Adekunle Raji

501 total citations
17 papers, 395 citations indexed

About

Adekunle Raji is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Adekunle Raji has authored 17 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Adekunle Raji's work include HER2/EGFR in Cancer Research (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Adekunle Raji is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Adekunle Raji collaborates with scholars based in United States, Canada and Greece. Adekunle Raji's co-authors include James M. Kozlowski, Beverly P. Nelson, Guang‐Yu Yang, Andrew M. Evens, Michael Pins, Paul T. Schumacker, Leo I. Gordon, Jane N. Winter, Michael R. Pins and Chadi Nabhan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Adekunle Raji

15 papers receiving 391 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adekunle Raji United States 9 218 156 140 76 75 17 395
Tatjana Walther Germany 6 171 0.8× 79 0.5× 84 0.6× 54 0.7× 57 0.8× 7 317
Karl Hsu United States 7 255 1.2× 168 1.1× 82 0.6× 38 0.5× 80 1.1× 14 433
Lurdes Torres Portugal 11 143 0.7× 101 0.6× 137 1.0× 44 0.6× 70 0.9× 20 328
Marion Chapellier France 12 153 0.7× 148 0.9× 93 0.7× 37 0.5× 43 0.6× 28 467
Kati Servan Germany 6 224 1.0× 119 0.8× 105 0.8× 49 0.6× 24 0.3× 6 389
Matias Casás‐Selves United States 8 350 1.6× 175 1.1× 126 0.9× 28 0.4× 71 0.9× 9 549
Eun Mi Je South Korea 12 254 1.2× 79 0.5× 117 0.8× 69 0.9× 91 1.2× 18 440
Susana Lisboa Portugal 12 241 1.1× 93 0.6× 90 0.6× 110 1.4× 41 0.5× 25 433
Suhong Xie China 15 278 1.3× 176 1.1× 126 0.9× 79 1.0× 82 1.1× 43 507
O. I. Olopade United States 9 209 1.0× 195 1.3× 136 1.0× 63 0.8× 52 0.7× 14 491

Countries citing papers authored by Adekunle Raji

Since Specialization
Citations

This map shows the geographic impact of Adekunle Raji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adekunle Raji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adekunle Raji more than expected).

Fields of papers citing papers by Adekunle Raji

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adekunle Raji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adekunle Raji. The network helps show where Adekunle Raji may publish in the future.

Co-authorship network of co-authors of Adekunle Raji

This figure shows the co-authorship network connecting the top 25 collaborators of Adekunle Raji. A scholar is included among the top collaborators of Adekunle Raji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adekunle Raji. Adekunle Raji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
2.
3.
Raji, Adekunle, et al.. (2021). Nasopharngeal Tuberculosis Simulating Cancer: About 2 Cases. European Journal of Medical and Health Sciences. 3(3). 46–48. 1 indexed citations
4.
Evens, Andrew M., Laurie H. Sehn, Pedro Farinha, et al.. (2010). Hypoxia-Inducible Factor-1 α Expression Predicts Superior Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP. Journal of Clinical Oncology. 28(6). 1017–1024. 56 indexed citations
5.
Zhang, Qiang, Brian T. Helfand, Thomas L. Jang, et al.. (2009). Nuclear Factor-κB-Mediated Transforming Growth Factor-β-Induced Expression of Vimentin Is an Independent Predictor of Biochemical Recurrence after Radical Prostatectomy. Clinical Cancer Research. 15(10). 3557–3567. 93 indexed citations
6.
Evens, Andrew M., Paul T. Schumacker, Irene Helenowski, et al.. (2008). Hypoxia inducible factor‐alpha activation in lymphoma and relationship to the thioredoxin family. British Journal of Haematology. 141(5). 676–680. 38 indexed citations
7.
Frankfurt, Olga, Elizabeth Hamilton, Adekunle Raji, et al.. (2008). Alemtuzumab and Rituximab Combination Therapy for Patients with Untreated CLL – a Phase II Trial.. Blood. 112(11). 2098–2098. 11 indexed citations
8.
Evens, Andrew M., Laurie H. Sehn, Pedro Farinha, et al.. (2008). Expression of Hypoxia-Inducible Factor (HIF) Is An Independent Favorable Prognostic Factor in Diffuse Large B-Cell Lymphoma (DLBCL) Treated with R-CHOP. Blood. 112(11). 479–479. 3 indexed citations
9.
Leyland‐Jones, Brian, Christine B. Ambrosone, John M.S. Bartlett, et al.. (2008). Recommendations for Collection and Handling of Specimens From Group Breast Cancer Clinical Trials. Journal of Clinical Oncology. 26(34). 5638–5644. 55 indexed citations
10.
Raji, Adekunle, et al.. (2007). Human epidermal growth factor receptor 2 testing recommendation.. PubMed. 131(9). 1330–1; author reply 1331. 2 indexed citations
11.
Bian, Y., Thomas J. Knobloch, Maureen Sadim, et al.. (2007). Somatic acquisition of TGFBR1*6A by epithelial and stromal cells during head and neck and colon cancer development. Human Molecular Genetics. 16(24). 3128–3135. 24 indexed citations
12.
Frankfurt, Olga, et al.. (2007). A Phase II Trial of Alemtizimab and Rituximab in Patients with Previously Untreated CLL.. Blood. 110(11). 2056–2056. 4 indexed citations
13.
Raji, Adekunle. (2007). Human Epidermal Growth Factor Receptor 2 Testing Recommendation. Archives of Pathology & Laboratory Medicine. 131(9). 1330–1331. 2 indexed citations
14.
Argiris, Athanassios, Thomas A. Hensing, Anjana V. Yeldandi, et al.. (2006). Combined Analysis of Molecular and Clinical Predictors of Gefitinib Activity in Advanced Non–Small Cell Lung Cancer: Epidermal Growth Factor Receptor Mutations Do Not Tell the Whole Story. Journal of Thoracic Oncology. 1(1). 52–60. 14 indexed citations
15.
Argiris, Athanassios, Thomas A. Hensing, Anjana V. Yeldandi, et al.. (2006). Combined Analysis of Molecular and Clinical Predictors of Gefitinib Activity in Advanced Non???Small Cell Lung Cancer: Epidermal Growth Factor Receptor Mutations Do Not Tell the Whole Story. Journal of Thoracic Oncology. 1(1). 52–60. 8 indexed citations
16.
17.
Pins, Michael R., Frederick K. Korley, M. Wong, et al.. (2004). Clusterin as a possible predictor for biochemical recurrence of prostate cancer following radical prostatectomy with intermediate Gleason scores: a preliminary report. Prostate Cancer and Prostatic Diseases. 7(3). 243–248. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tatjana Walther Breakdown of academic impact, for papers by Karl Hsu Breakdown of academic impact, for papers by Lurdes Torres Breakdown of academic impact, for papers by Marion Chapellier Breakdown of academic impact, for papers by Kati Servan Breakdown of academic impact, for papers by Matias Casás‐Selves Breakdown of academic impact, for papers by Eun Mi Je Breakdown of academic impact, for papers by Susana Lisboa Breakdown of academic impact, for papers by Suhong Xie Breakdown of academic impact, for papers by O. I. Olopade
Rankless by CCL
2026